Endovascular treatment for acute and chronic brain ischemia

Current Opinion in Neurology

Volumn 9, Issue 1, 1996, Pages 62-67

  Clark, Wayne M ^a,b   Barnwell, Stanley L ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; UROKINASE;

BLOOD VESSEL CATHETERIZATION; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; SHORT SURVEY; TRANSLUMINAL CORONARY ANGIOPLASTY; VASOSPASM;

EID: 0029940920     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199602000-00013     Document Type: Short Survey

References (48)

1. Russell D, Madden KP, Clark WM, Zivin J: Tissue plasminogen activator induced cerebral thrombolysis: assessment of different dose rates using Doppler ultrasound. Stroke 1992, 23:388-393.
2. Brückmann H, Ringelstein EB, Buchner H, Zeumer H: Percutaneous transluminal angioplasty of the vertebral artery. A therapeutic alternative to operative reconstruction of proximal vertebral artery stenoses. J Neurol 1986, 233:336-339.
3. Higashida RT, Tsai FY, Halbach VV, Dowd CF, Smith T, Fraser K, Hieshima GB: Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993, 78:192-198.
4. Higashida R, Tsai F, Halbach V: Cerebral percutananeous transluminal angioplasty. Heart Dis Stroke 1993, 2:497-503.
5. Bockenheimer SA, Mathias K: Percutaneous transluminal angioplasty in arteriosclerotic internal carotid artery stenosis. AJNR 1983, 4:791-792.
6. Damuth HD Jr, Diamond AB, Rappoport AS: Angioplasty of subclavian artery stenosis proximal to the vertebral origin. AJNR 1983, 4: 1239-1242.
7. Galichia JP, Bajaj AK, Vine DL: Subclavian artery stenosis treated by transluminial angioplasty: six cases. Cardiovasc Intervent Radiol 1983, 6:78-81.
8. Higashida RT, Hieshima GB, Tsai FY, Halbach VV, Norman D, Newton TH: Transluminal angioplasty of the vertebral and basilar artery. AJNR 1987, 8:745-749.
9. Garrido E, Montoya J: Transluminal dilatation of internal carotid artery in fibromuscular dysplasia: a preliminary report. Surg Neurol 1981, 16:469-471
10. Hasso AN, Zinke DE, Thompson JR: Fibromuscular dysplasia of the internal carotid artery. ANJR 1986, 2:175-180.
11. Kori SH: Interventional neurology: a subspecialty whose time has come. Neurology 1993, 43:2395-2399.
12. Higashida RT, Tsai FY, Halbach VV, Barnwell SL, Dowd CF, Hieshima GB: Interventional neurovascular techniques in the treatment of stroke -state-of-the-art therapy. J Intern Med 1995, 237:105-115. A superb clinical review on a large number of interventionally treated patients. The authors treated 18 intracranial vessels with PTCA and had a 75% successful vessel opening rate The authors also used PTCA to treat symptomatic vasospasm secondary to subarachnoid hemorrhage in 28 patients with 99 symptomatic arteries. All cases had angiographic documented improvement in vessel diameter. The authors then describe their experience using intra-arterial thrombolytic therapy in 24 patients treated within 12h of stroke. Successful clot lysis occurred in 80% of the cases with 62% showing neurologic improvement.
13. Marks M, Norbash A, Clark J, Albers G, Steinberg G: Angioplasty of intracranial stenosis. Stroke 1995, 26:159.
14. Touho H: Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. J Neurosurg 1995, 82:953-960. An important clinical study of 19 patients treated with PTCA. The procedure was successful in 13 cases with the average stenosis before treatment of 83±8% being reduced to 35±17% post-treatment. The patients with the greatest improvements in symptoms were the ones who showed the most improvement in cerebral blood flow measured with SPECT scans. To reduce the risk of emboli associated with PTCA, the author describes a new coaxial balloon catheter system.
15. Touho H, Ohnishi H, Karasawa J, Furuoka N, Komatsu T: Percutaneous transluminal angioplasty for acute stroke due to stenosis of major cerebral vessels: report of two cases. Surg Neurol 1994, 41:362-367.
16. Clark W, Barnwell S, Nesbit G, O'Neill O, Wynn M, Coull B: Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995, 26:1200-1204. The authors describe their experience using PTCA in 22 intracranial vessels in 17 selected patients. All patients had at least 70% stenosis and were symptomatic despite optimal medical therapy. Stenosis prior to angioplasty averaged 72±8% with an improvement seen after angioplasty to 43±23%. There were two angioplasty related strokes resulting in a per vessel complication rate of 9%.
17. Yamamoto Y, Smith RR, Bernanke DH: Mechanism of action of balloon angioplasty in cerebral vasospasm. Neurosurgery 1992, 30:1-6.
18. Newell DW, Eskridge JM, Mayberg MR, Grady MS, Winn HR: Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 1989, 71:654-660.
19. Zubkov YN, Nikiforov BM, Shustin VA: Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir 1984, 70:65-79.
20. Higashida RT, Halbach VV, Cahan LD, Brant Z, Barnwell S, Dowd C, Hieshim G: Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989, 71:648-653.
21. Ropper AH, Zervas NT: Outcome one year after subarachnoid hemorrhage from cerebral aneurysms. J Neurosurg 1984, 60:909-915.
22. Coyne T, Montanera W, Macdonald R, Wallace C: Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg 1994, 37:391-396. The authors describe their experience using PTCA to treat 31 vessels in 13 cases of symptomatic vasospasm. Angioplasty was successful angiographically in all of the arteries treated. Immediate neurologic improvement was noted in 31% of the cases and there were no PTCA related complications.
23. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marier JR: Urgent therapy for stroke, I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992, 23:632-640.
24. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A: Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992, 42:976-982.
25. von Kummer R, Hacke W: Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992, 23:646-652.
26. Wardlaw JM, Warlow CP: Thrombolysis in acute ischemic stroke: does it work? Stroke 1992, 23:1826-1839.
27. Hamilton MG, Lee JS, Cummings PJ, Zabramski JM: A comparison of intraarterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits. Stroke 1994, 25:651-656.
28. Zeumer H, Freitag HJ, Grzyska U, Neunzig HP: Local intraarterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology 1989, 31:336-340.
29. Möbius E, Berg-Dammer E, Kühne D, Ahser HC: Local thrombolytic therapy in acute basilar artery occlusion: experience with 18 patients. In Thrombolytic therapy in acute ischemic stroke. Edited by Hacke W, del Zoppo GJ, Hirschberg M. Heidelberg: Springer-Verlag; 1991:213-215.
30. Pfeiffer G, Thayssen G, Arlt A, Siepmann G, Zeumer H, Kunze K: Vertebrobasilar occlusion: outcome with and without local intraarterial fibrinolysis. In Thrombolytic therapy in acute ischemic stroke. Edited by Hacke W, del Zoppo GJ, Hirschberg M. Heidelberg: Springer-Verlag, 1991:216-220.
31. Matsumoto K, Satoh K: Topical intraarterial urokinase infusion for acute stroke. In Thrombolytic therapy in acute ischemic stroke. Edited by Hacke W, del Zoppo GJ, Hirschberg M. Heidelberg: Springer-Verlag; 1991: 207-212.
32. del Zoppo GJ, Ferbert A, Otis S, Bruckmann H, Hacke W, Zyroff J, Harker L, Zeumer H: Local intraarterial flbrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke 1988, 19:307-313.
33. Mori E: Fibrinolytic recanalization therapy in acute cerebrovascular thromboembolism. In Thrombolytic therapy in acute ischemic stroke. Edited by Hacke W, del Zoppo GJ, Hirschberg M. Heidelberg: Springer-Verlag; 1991:137-146.
34. Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganem F, Maiza D: Local intra-arterial fibrinolysis in the carotid territory. AJNR 1989, 10:753-765.
35. Casto L, Moschini L, Camerlingo M, Gazzaniga G, Partziguain T, Belloni G, Mamoli A: Local intraarterial thrombolysis for acute stroke in the carotid artery territories. Acta Neurol Scand 1992, 86:308-311.
36. Hacke W, Zeumer H, Ferbert A, Brückmann H, del Zoppo G: Intraarterial thrombolytic therapy improves outcome in patients with acute vertobro-basiliar occulsive disease. Stroke 1988, 19:1216-1222.
37. Sasaki O, Shigekazu T, Koike T, Koizumi T, Tanaka R: Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intraarterial local approaches. Neurosurgery 1995, 36:246-253. The authors describe thrombolysis results from a nonrandomized consecutive trial using either direct intraarterial therapy, local intercarotid therapy, or intravenous therapy in 90 patients treated within 8 h of an acute stroke. The rate of recanalization in the direct intraarterial group was 84%, compared with just 11% in the local thrombolytic group. For patients with MCA stroke, the rate of recovery in the intraarterial group was 44% compared with 19% in the locally treated group and 33% in the intravenous group.
38. Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T: Evaluation of risk of hemorrhagic transformation in local intraarterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994, 25:298-303. The authors describe direct intraarterial urokinase treatment in 34 patients with negative head computed tomography scans treated within 6 h. They report a 94% rate of vessel recanalization and a 65% rate of neurologic recovery at 1 month. An important finding of this study is that in the 21% of patients who had hemorrhagic transformation, the SPECT scans performed prior to treatment showed significantly lower cerebral blood flow compared with the patients who did not develop hemorrhages.
39. Barr JD, Mathis JM, Wildenhain SL, Wechsler L, Jungreis CA, Horton JA: Acute stroke intervention with intraarterial urokinase infusion. J Vas Intervent Radiol 1994, 5:705-713. Twelve patients treated with direct intraarterial urokinase within 8 h of stroke are described. Thrombolysis was angiographically successful in 75% of the patients, all of whom had good neurologic recovery.
40. Wildenhain SL, Jungreis CA, Barr J, Mathis J, Wechsler L, Norton JA: CT after intracranial thrombolysis for acute stroke. AJNR 1994, 15: 487-492. The authors make the interesting point that some of the 'hemorrhages' found after intraarterial treatment may actually be extravasated contrast material.
41. Barr JD, Horowitz MB, Mathis JM, Sclabasst RJ, Yonas H: Intraoperative urokinase infusion for embolic stroke during carotid endarterectomy. Neurosurgery 1995, 36:606-611.
42. Touho H, Karasawa J, Hideyuki O, Nakase H, Furuoka N, Takaoka M, Komatsu T: Successful intraarterial fibrinolysis of the anterior choroidal artery in the acute stage of internal carotid artery occlusion: case report. Surg Neurol 1994, 41:450-454.
43. Clark W, Barnwell S, O'Neill O, Ahuja A, Wynn M, Coull B: Successful middle cerebral artery thrombolysis by microcatheter navigation through an occluded internal carotid artery. Stroke 1995, 26:167.
44. Tsai FY, Berberian B, Matovich V, Lavin M, Alfieri K: Percutaneous transluminal angioplasty adjunct to thrombolysis for acute middle cerebral artery rethrombosis. AJNR 1994, 15:1823-1829. Three cases are described in which the vessel acutely reoccluded after a successful MCA thrombolysis. The authors reopened the vessel with thrombolysis and then did complimentary PTCA to prevent rethrombosis.
45. Barnwell SL, Clark WM, Nguyen T, O'Neill O, Wynn M, Coull B: Safety and efficacy of delayed intra-arterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR 1994, 15:1817-1822. In this paper direct intraarterial treatment is described in 13 patients with acute ischemic stroke. Successful thrombolysis was obtained in 77% of the patients. Nine out of 13 of the patients showed major neurologic improvement as measured by the National Institutes of Health stroke scale. An important point of this paper is that rather than limiting the patients to stroke within 6 h, the authors used a negative computed tomography scan as the criteria for entrance. Several of the basalar artery strokes were treated after 24 h of symptom onset.
46. Ueda T, Hatakeyama T, Sakaki S, Ohta S, Kumon Y, Uraoka T: Changes in coagulation and fibrinolytic system after local intraarterial thrombolyis for acute ischemic stroke. Neurol Med Chir 1995, 35:136-143. The results of this study suggest that even with direct intraarterial treatment, there are changes in the systemic fibrinolytic system. Patients who developed hemorrhagic infarctions after treatment were those who had the highest level of fibrinogen degradation products.
47. Smith TP, Higashida RT, Barnwell SL, Halbach VV, Dowd CF, Fraser KW, Teitelbaum GP, Hieshima GB: Treatment of durai sinus thrombosis by urokinase infusion. AJNR 1994, 15:801-807. The authors describe direct intravenous treatment in seven patients with sinus thrombosis. Six out of the seven had a good neurologic recovery.
48. Horowitz M, Purdy P, Unwin H, Carstens G, Greenlee R, Hise J, Kopitnik T, Batjer H, Rollins N, Samson D: Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol 1995, 35: 58-67. Twelve cases of dural sinus thrombosis treated with direct urokinase are described. Sinus patency was documented in 11 cases following treatment with a good clinical outcome occurring in 10 of them.